Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Primary Completion Date

January 31, 2006

Conditions
Penile Cancer
Interventions
DRUG

cisplatin

DRUG

irinotecan hydrochloride

PROCEDURE

neoadjuvant therapy

Trial Locations (8)

1122

National Institute of Oncology, Budapest

B-3000

U.Z. Gasthuisberg, Leuven

F-94805

Institut Gustave Roussy, Villejuif

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

02-781

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

EC1A 7BE

Saint Bartholomew's Hospital, London

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00066391 - Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | Biotech Hunter | Biotech Hunter